U1867209/National Natural Science Foundation of China[Grants and Funding] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2021	1
2022	2
2023	1
2025	0

Page 1

Fatty acid-conjugated radiopharmaceuticals for fibroblast activation protein-targeted radiotherapy.

Zhang P, Xu M, Ding J, Chen J, Zhang T, Huo L, Liu Z. Zhang P, et al. Eur J Nucl Med Mol Imaging. 2022 May;49(6):1985-1996. doi: 10.1007/s00259-021-05591-x. Epub 2021 Nov 8. Eur J Nucl Med Mol Imaging. 2022. PMID: 34746969

Organotrifluoroborate enhances tumor targeting of fibroblast activation protein inhibitors for targeted radionuclide therapy.

Liu Y, Tang H, Song T, Xu M, Chen J, Cui XY, Han Y, Li Z, Liu Z. Liu Y, et al. Eur J Nucl Med Mol Imaging. 2023 Jul;50(9):2636-2646. doi: 10.1007/s00259-023-06230-3. Epub 2023 Apr 27. Eur J Nucl Med Mol Imaging. 2023. PMID: 37103565

Larger ¹⁸F-fluoroboronotyrosine (FBY) active volume beyond MRI contrast enhancement in diffuse gliomas than in circumscribed brain tumors.

Kong Z, Li Z, Chen J, Ma W, Wang Y, Yang Z, Liu Z. Kong Z, et al. EJNMMI Res. 2022 Apr 18;12(1):22. doi: 10.1186/s13550-022-00896-w. EJNMMI Res. 2022. PMID: 35435593 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year